CAT-1-mediated arginine uptake and regulation of nitric oxide synthases for the survival of human breast cancer cell lines

Journal of Cellular Biochemistry

Volumn 112, Issue 4, 2011, Pages 1084-1092

  Abdelmagid, Salma A ^a   Rickard, Jenaya A ^a   McDonald, William J ^a   Thomas, Lynn N ^a   Too, Catherine K L ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Arginine uptake; Breast cancer; Cationic amino acid transporter; Nitric oxide synthases

Indexed keywords

AMINO ACID TRANSPORTER; ARGININE; CATIONIC AMINO ACID TRANSPORTER 2A; CATIONIC AMINO ACID TRANSPORTER 2B; CATIONIC AMINO ACID TRANSPORTER 4; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTRADIOL; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; PROLACTIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

AMINO ACID TRANSPORT; APOPTOSIS; ARTICLE; BREAST CANCER; CELL NUCLEUS; CELL STRAIN MCF 7; CELL VIABILITY; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

APOPTOSIS; ARGININE; BIOLOGICAL TRANSPORT; BLOTTING, WESTERN; BREAST NEOPLASMS; CATIONIC AMINO ACID TRANSPORTER 1; CATIONIC AMINO ACID TRANSPORTER 2; CELL LINE, TUMOR; CELL NUCLEUS; CELL SURVIVAL; CYTOPLASM; ESTRADIOL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROSCOPY, CONFOCAL; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PROLACTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

EID: 79952564943     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23022     Document Type: Article

References (45)

1. Abdelmagid SA, Too CKL. 2008. Prolactin and estrogen up-regulate carboxypeptidase-D to promote nitric oxide production and survival of MCF-7 breast cancer cells. Endocrinology 149:4821-4828.
2. Arancibia-Garavilla Y, Toledo F, Casanello P, Sobrevia L. 2003. Nitric oxide synthesis requires activity of the cationic and neutral amino acid transport system y+L in human umbilical vein endothelium. Exp Physiol 88:699-710. (Pubitemid 37483900)
3. Bani D, Masini E, Bello MG, Bigazzi M, Sacchi TB. 1995. Relaxin activates the L-arginine-nitric oxide pathway in human breast cancer cells. Cancer Res 55:5272-5275.
4. Baydoun AR, Wileman SM, Wheeler-Jones CP, Marber MS, Mann GE, Pearson JD, Closs EI. 1999. Transmembrane signalling mechanisms regulating expression of cationic amino acid transporters and inducible nitric oxide synthase in rat vascular smooth muscle cells. Biochem J 1(344 Pt): 265-272.
5. Beckman JS, Koppenol WH. 1996. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271:C1424-1437.
6. Caso G, McNurlan MA, McMillan ND, Eremin O, Garlick PJ. 2004. Tumour cell growth in culture: Dependence on arginine. Clin Sci (Lond) 107:371-379. (Pubitemid 39389304)
7. 2+ mobilization. Circ Res 81:885-892.
8. Closs EI. 2002. Expression, regulation and function of carrier proteins for cationic amino acids. Curr Opin Nephrol Hypertens 11:99-107. (Pubitemid 34053345)
9. Deves R, Boyd CA. 1998. Transporters for cationic amino acids in animal cells: Discovery, structure, and function. Physiol Rev 78:487-545. (Pubitemid 28182902)
10. Dodd F, Limoges M, Boudreau RT, Rowden G, Murphy PR, Too CKL. 2000. L-arginine inhibits apoptosis via a NO-dependent mechanism in Nb2 lymphoma cells. J Cell Biochem 77:624-634. (Pubitemid 30332002)
11. Durante W, Liao L, Iftikhar I, Cheng K, Schafer AI. 1996. Platelet-derived growth factor regulates vascular smooth muscle cell proliferation by inducing cationic amino acid transporter gene expression. J Biol Chem 271: 11838-11843. (Pubitemid 26157255)
12. Dye JF, Vause S, Johnston T, Clark P, Firth JA, D'Souza SW, Sibley CP, Glazier JD. 2004. Characterization of cationic amino acid transporters and expression of endothelial nitric oxide synthase in human placental microvascular endothelial cells. FASEB J 18:125-127.
13. Fernandez J, Bode B, Koromilas A, Diehl JA, Krukovets I, Snider MD, Hatzoglou M. 2002. Translation mediated by the internal ribosome entry site of the CAT-1 mRNA is regulated by glucose availability in a PERK kinase-dependent manner. J Biol Chem 277:11780-11787. (Pubitemid 34952733)
14. Fleming I, Bauersachs J, Schafer A, Scholz D, Aldershvile J, Busse R. 1999. Isometric contraction induces the Ca2+-independent activation of the endothelial nitric oxide synthase. Proc Natl Acad Sci USA 96:1123-1128.
15. Fukumura D, Kashiwagi S, Jain RK. 2006. The role of nitric oxide in tumour progression. Nat Rev Cancer 6:521-534. (Pubitemid 43980541)
16. Geller DA, Billiar TR. 1998. Molecular biology of nitric oxide synthases. Cancer Metastasis Rev 17:7-23. (Pubitemid 28194643)
17. Gilchrist M, McCauley SD, Befus AD. 2004. Expression, localization, and regulation of NOS in human mast cell lines: Effects on leukotriene production. Blood 104:462-469. (Pubitemid 38900029)
18. Hosokawa H, Sawamura T, Kobayashi S, Ninomiya H, Miwa S, Masaki T. 1997. Cloning and characterization of a brain-specific cationic amino acid transporter. J Biol Chem 272:8717-8722. (Pubitemid 27147840)
19. Ito K, Groudine M. 1997. A new member of the cationic amino acid transporter family is preferentially expressed in adult mouse brain. J Biol Chem 272:26780-26786. (Pubitemid 27458907)
20. Joy S, Siow RC, Rowlands DJ, Becker M, Wyatt AW, Aaronson PI, Coen CW, Kallo I, Jacob R, Mann GE. 2006. The isoflavone Equol mediates rapid vascular relaxation: Ca2+-independent activation of endothelial nitricoxide synthase/Hsp90 involving ERK1/2 and Akt phosphorylation in human endothelial cells. J Biol Chem 281:27335-27345. (Pubitemid 44401761)
21. Kone BC, Kuncewicz T, Zhang W, Yu ZY. 2003. Protein interactions with nitric oxide synthases: Controlling the right time, the right place, and the right amount of nitric oxide. Am J Physiol Renal Physiol 285:F178-190.
22. Mann GE, Yudilevich DL, Sobrevia L. 2003. Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells. Physiol Rev 83:183-252. (Pubitemid 36459881)
23. Mendes Ribeiro AC, Brunini TM, Yaqoob M, Aronson JK, Mann GE, Ellory JC, 1999. Identification of system y+L as the high-affinity transporter for L-arginine in human platelets: Up-regulation of L-arginine influx in uraemia. Pflugers Arch 438:573-575. (Pubitemid 29419915)
24. Mortensen K, Skouv J, Hougaard DM, Larsson LI. 1999. Endogenous endothelial cell nitric-oxide synthase modulates apoptosis in cultured breast cancer cells and is transcriptionally regulated by p53. J Biol Chem 274: 37679-37684. (Pubitemid 30026826)
25. Nathan C, Xie QW. 1994. Nitric oxide synthases: Roles, tolls, and controls. Cell 78:915-918. (Pubitemid 24292319)
26. O'Malley PG, Sangster SM, Abdelmagid SA, Bearne SL, Too CKL. 2005. Characterization of a novel, cytokine-inducible carboxypeptidase D isoform in haematopoietic tumour cells. Biochem J 390:665-673. (Pubitemid 41395348)
27. Pan J, Burgher KL, Szczepanik AM, Ringheim GE. 1996. Tyrosine phosphorylation of inducible nitric oxide synthase: Implications for potential posttranslational regulation. Biochem J 314(Pt 3): 889-894. (Pubitemid 26097752)
28. Pance A. 2006. Nitric oxide and hormones in breast cancer: Allies or enemies? Future Oncol 2:275-288.
29. Racke K, Hey C, Mossner J, Hammermann R, Stichnote C, Wessler I. 1998. Activation of L-arginine transport by protein kinase C in rabbit, rat and mouse alveolar macrophages. J Physiol 511(Pt 3): 813-825. (Pubitemid 28456909)
30. Reveneau S, Arnould L, Jolimoy G, Hilpert S, Lejeune P, Saint-Giorgio V, Belichard C, Jeannin JF. 1999. Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptors. Lab Invest 79:1215-1225. (Pubitemid 29489446)
31. Saini R, Patel S, Saluja R, Sahasrabuddhe AA, Singh MP, Habib S, Bajpai VK, Dikshit M. 2006. Nitric oxide synthase localization in the rat neutrophils: Immunocytochemical, molecular, and biochemical studies. J Leukoc Biol 79:519-528. (Pubitemid 44831229)
32. Shaul PW, Smart EJ, Robinson LJ, German Z, Yuhanna IS, Ying Y, Anderson RG, Michel T. 1996. Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem 271:6518-6522. (Pubitemid 26095467)
33. Shiu RP. 1979. Prolactin receptors in human breast cancer cells in long-term tissue culture. Cancer Res 39:4381-4386. (Pubitemid 10197592)
34. Signorello MG, Pascale R, Leoncini G. 2003. Transport of L-arginine and nitric oxide formation in human platelets. Eur J Biochem 270:2005-2012. (Pubitemid 36560822)
35. Simmons WW, Closs EI, Cunningham JM, Smith TW, Kelly RA. 1996. Cytokines and insulin induce cationic amino acid transporter (CAT) expression in cardiac myocytes. Regulation of L-arginine transport and no production by CAT-1, CAT-2A, and CAT-2B. J Biol Chem 271:11694-11702.
36. Singh R, Pervin S, Karimi A, Cederbaum S, Chaudhuri G. 2000. Arginase activity in human breast cancer cell lines: N(omega)-hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells. Cancer Res 60:3305-3312. (Pubitemid 30407931)
37. Sobrevia L, Gonzalez M. 2009. A role for insulin on L-arginine transport in fetal endothelial dysfunction in hyperglycaemia. Curr Vasc Pharmacol 7: 467-474.
38. Sperandeo MP, Borsani G, Incerti B, Zollo M, Rossi E, Zuffardi O, Castaldo P, Taglialatela M, Andria G, Sebastio G. 1998. The gene encoding a cationic amino acid transporter (SLC7A4) maps to the region deleted in the velocardiofacial syndrome. Genomics 49:230-236. (Pubitemid 28240689)
39. Stevens BR, Kakuda DK, Yu K, Waters M, Vo CB, Raizada MK. 1996. Induced nitric oxide synthesis is dependent on induced alternatively spliced CAT-2 encoding L-arginine transport in brain astrocytes. J Biol Chem 271:24017-24022. (Pubitemid 26327380)
40. Thomsen LL, Miles DW. 1998. Role of nitric oxide in tumour progression: Lessons from human tumours. Cancer Metastasis Rev 17:107-118. (Pubitemid 28194649)
41. Vekony N, Wolf S, Boissel JP, Gnauert K, Closs EI. 2001. Human cationic amino acid transporter hCAT-3 is preferentially expressed in peripheral tissues. Biochemistry 40:12387-12394. (Pubitemid 32959761)
42. Weigel RJ, deConinck EC. 1993. Transcriptional control of estrogen receptor in estrogen receptor-negative breast carcinoma. Cancer Res 53:3472-3474.
43. Wolf S, Janzen A, Vekony N, Martine U, Strand D, Closs EI. 2002. Expression of solute carrier 7A4 (SLC7A4) in the plasma membrane is not sufficient to mediate amino acid transport activity. Biochem J 364:767-775. (Pubitemid 34680853)
44. Wu G, Morris SM, Jr. 1998. Arginine metabolism: Nitric oxide and beyond. Biochem J 336(Pt 1): 1-17. (Pubitemid 28532555)
45. Wu Y, Shen D, Chen Z, Clayton S, Vadgama JV. 2007. Taxol induced apoptosis regulates amino acid transport in breast cancer cells. Apoptosis 12:593-612.